Markus‐Frederik Bohn
Impact in
- Virology top 2%
- HIV Research and Treatment
-
- CRISPR and Genetic Engineering
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- RNA regulation and disease
Papers in
-
- Biochemical and Structural Characterization 6
- Epigenetics and DNA Methylation 2
- Genetics 9
- Venomous Animal Envenomation and Studies 7
- Co-authors
- Celia A. Schiffer (6 shared papers)Shivender M.D. Shandilya (5 shared papers)Charles S. Craik (9 shared papers)Mohan Somasundaran (3 shared papers)Takahide Kouno (3 shared papers)Brian A. Kelch (2 shared papers)Neşe Kurt Yılmaz (2 shared papers)Tania V. Silvas (2 shared papers)
- Journals
- Protein Science (3 papers)Structure (2 papers)Toxicon (2 papers)Scientific Reports (1 paper)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)
- Partner nations
- United StatesDenmarkNorway
In The Last Decade
Markus‐Frederik Bohn
23 papers receiving 786 citations
Peers
Comparison fields: 5 of 71
- Virology 222
- Molecular Biology 543
- Immunology 128
- Infectious Diseases 98
- Oncology 143
Countries citing papers authored by Markus‐Frederik Bohn
This map shows the geographic impact of Markus‐Frederik Bohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus‐Frederik Bohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus‐Frederik Bohn more than expected).
Fields of papers citing papers by Markus‐Frederik Bohn
This network shows the impact of papers produced by Markus‐Frederik Bohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus‐Frederik Bohn. The network helps show where Markus‐Frederik Bohn may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus‐Frederik Bohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 115 | |
| 2 | 2012 | 111 | |
| 3 | 2022 | 86 | |
| 4 | 2013 | 83 | |
| 5 | 2015 | 70 | |
| 6 | 2019 | 59 | |
| 7 | 2017 | 59 | |
| 8 | 2017 | 33 | |
| 9 | 2016 | 29 | |
| 10 | 2021 | 26 | |
| 11 | 2014 | 23 | |
| 12 | 2022 | 22 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2024 | 8 | |
| 17 | 2023 | 8 | |
| 18 | 2022 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2023 | 6 |
About Markus‐Frederik Bohn
Markus‐Frederik Bohn is a scholar working on Molecular Biology, Genetics, Virology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 788 indexed citations. Recurring topics across this work include Venomous Animal Envenomation and Studies (7 papers), Biochemical and Structural Characterization (6 papers), HIV Research and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Cytomegalovirus and herpesvirus research (3 papers), HIV/AIDS drug development and treatment (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Virology (222 citations), Molecular Biology (543 citations), Immunology (128 citations), Infectious Diseases (98 citations) and Oncology (143 citations). Markus‐Frederik Bohn has collaborated with scholars based in United States, Denmark and Norway. Frequent co-authors include Celia A. Schiffer, Shivender M.D. Shandilya, Charles S. Craik, Mohan Somasundaran, Takahide Kouno, Brian A. Kelch, Neşe Kurt Yılmaz, Tania V. Silvas, Hiroshi Matsuo and Michael A. Carpenter. Their work appears in journals such as Protein Science, Structure, Toxicon, Scientific Reports and Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.